A panel of medical experts discuss the current treatment landscape surrounding atopic dermatitis.
EP. 1: Atopic Dermatitis Overview
Casey Butrus, PharmD, leads a panel of experts in a discussion surrounding atopic dermatitis.
EP. 2: Diagnostic Challenges Facing Patients with Atopic Dermatitis
Key opinion leaders navigate diagnostic challenges associated with atopic dermatitis.
EP. 3: Patient Journey and Presentations of Atopic Dermatitis
Dr Casey Butrus drives a discussion highlighting typical patient presentations of AD.
EP. 4: Treatment Landscape Surrounding Atopic Dermatitis
Brian Keegan, MD, PhD, and Michael Cameron, MD, FAAD, describe treatment options for patients with atopic dermatitis.
EP. 5: Topical vs Systemic Treatment for AD
Medical experts navigate the selection process for optimal atopic dermatitis treatment strategies from provider and payer perspectives.
EP. 6: Typical Onset of Action to Relieve Itch Associated with Atopic Dermatitis
Managing itch associated with atopic dermatitis is a critical intervention to patient quality of life.
EP. 7: Ruxolitinib in Treatment of Atopic Dermatitis
The panelists highlight the treatment nature of ruxolitinib, a JAK inhibitor used to treat atopic dermatitis.
EP. 8: Selecting Appropriate Patient Populations for Ruxolitinib
Dr Butrus leads a discussion on the ideal patient population for treating atopic dermatitis with ruxolitinib.
EP. 9: JAK Inhibitor Usage Benefiting an Array of Dermatological Conditions
Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions.
EP. 10: Patient-Specific Characteristics Driving AD Treatment Regimen
Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
2 Clarke Drive Cranbury, NJ 08512